2023

This Just In: Irwin Naturals Secures $40 Million Financing for Current Operations What Does This Mean for the Psychedelic Mental Health Clinic Rollup? Exciting news from Irwin Naturals Inc.! The company has secured a credit facility for $60 million, with $40 million already committed. This funding will support Irwin Naturals’ current operations, including their innovative…

Welcome to the PlanSource Partner Marketplace! Exciting News! Hey there, HR professionals and benefits enthusiasts! Have you heard the latest update from PlanSource? Well, if you haven’t, let me fill you in on the juicy details. PlanSource, the go-to provider of cloud-based benefits administration technology, has just welcomed 13 new partners to their already impressive…

Coherent Corp. has recently introduced a groundbreaking automated laser system, the AP 530 S, designed specifically for texturing and marking implantable medical devices. This cutting-edge technology represents a significant advancement in the field of laser processing systems, solidifying Coherent’s position as a leader in the industry. Implantable medical devices play a crucial role in modern…

The post-Fed Optimism Boosts Equities in European Trade Continuation of Market Positivity The post-Fed optimism is continuing to flow with equities holding higher to start European morning trade, with the dollar slightly on the lower side at the moment. Recent inflation data from the US has helped to vindicate the market outlook that we are…

The Central Bank Bonanza Continues Diving into the Markets It’s another positive day in the stock markets, with Eurostoxx up by 0.7%, Germany DAX by 0.6%, France CAC 40 by 0.5%, UK FTSE by 0.3%, and Spain IBEX by 0.7%. This carries over from the positive momentum yesterday, with S&P 500 futures also seen up…

Company Financial Tradition Reports 89% Increase in Q4 2022 Revenue Description: Compagnie Financière Tradition (CFT), a Swiss interdealer broker and operator of a Japanese retail broking giant, reported the consolidated revenue as CHF 231.1 for the fourth quarter of 2022. The figure jumped from CHF 219 million generated in the last three months of the…

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock BRISBANE, Calif., Feb. 01, 2023 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc., (NasdaqGM: VERA; “Vera”), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the pricing of its previously announced underwritten public offering of…

SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors, and location SAN FRANCISCO, Feb. 01, 2023 (GLOBE NEWSWIRE) — Anticipation and excitement builds for the 2023 SynBioBeta Global Synthetic Biology Conference with global innovation network SynBioBeta announcing today event dates, keynotes, sponsors, and conference location. Set to be the largest synthetic…